Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Roger Olofsson Bagge

Docent

Roger Olofsson Bagge
Docent
roger.olofsson@gu.se

Besöksadress: Avdelningen för kirurgi, Blå stråket 5, SU/Sahlgrenska , 41345 Göteborg


Avd för kirurgi vid Institutionen för kliniska vetenskaper (Mer information)
Sahlgrenska Universitetssjukhuset
413 45 Göteborg
Besöksadress: Blå stråket 5, vån 3 SU/Sahlgrenska , 413 45 Göteborg

Om Roger Olofsson Bagge

Roger Olofsson Bagge is an Associate professor at the Institute of Clinical Sciences at Sahlgrensska Academy. He is also a Senior consultant surgeon, the Head of Breast and Melanoma Surgery at the Department Surgery and the Director of Sahlgrenska Breast Cancer Center at the Sahlgrenska University Hospital.

He has a research group including both clinical and pre-clinical research within Wallenberg Centre of Molecular and Translational Medicine where the focus is translational cancer research, mainly concerning malignant melanoma and breast cancer.

Link to Rogers Olofsson Bagges research group

Examples of ongoing projects

  1. ExoBioMark - Translational biomarker study including patients with breast cancer and melanoma
  2. SCANDIUM - A phase III randomized controlled trial evaluating isolated hepatic perfusion (IHP) vs. Best alternative care (BAC) (NCT01785316).
  3. SCANDIUM II - A phase I randomized controlled trial evaluating isolated hepatic perfusion (IHP) and immunotherapy using ipilimumab and nivolumab.
  4. MI-ILP - Minimally-invasive isolated limb perfusion (NCT03376126).
  5. Nivo-ILP - Double blind randomized controlled phase Ib/II trial evaluating the effect of adding nivolumab to isolated limb perfusion (NCT03685890). 
  6. SUMMIST - Randomized controlled phase II trial evaluating the effect of metastasectomies in patients with stable disease or partial response after treatment with PD-1 inhibition (NCT04242329).
  7. MAGMEN - Identification and prediction of sentinel node status in melanoma using supraparamagnetic iron oxide nanoparticles and MRI (NCT03898687). 

Finalized PhD-projects

  1. Main supervisor - Valerio Belgrano. Thesis presented 2019-06-04
  2. Assistant supervisor - Junko Johansson. Thesis presented 2019-05-29
  3. Assistant supervisor - Elin Söderberg. Thesis presented 2020-01-10

Ongoing PhD-projects

  1. Main supervisor - Jenny Heiman Ullmark
  2. Main supervisor - Nushin Mirzaei
  3. Main supervisor - Hafsteinn Petursson
  4. Main supervisor - Lida Pistioli
  5. Main supervisor - Anna Corderfeldt
  6. Main supervisor - Carl-Jacob Holmberg
  7. Assistant supervisor - Slavica Janeva

Major research funding

  • Swedish Cancer Society
  • Wallenberg Foundation
  • Region Västra Götaland
  • Assar Gabrielsson foundation
  • Gothenburg Medical Association
  • Swedish state (ALF-agreement)
  • Gothenburg research council

https://orcid.org/0000-0001-5795-0355

 

Senaste publikationer

Effect of delay between nuclear medicine scanning and sentinel node biopsy on outcome in patients with cutaneous melanoma
M. D. Moncrieff, F. M. O'Leary, C. J. Beadsmoore, D. Pawaroo, M. J. Heaton et al.
British Journal of Surgery, Artikel i vetenskaplig tidskrift 2020
Artikel i vetenskaplig tidskrift

The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer
J. de Boniface, J. Ahlgren, Y. Andersson, L. Bergkvist, J. Frisell et al.
Breast Cancer Research and Treatment, Artikel i vetenskaplig tidskrift 2020
Artikel i vetenskaplig tidskrift

A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III Cutaneous Malignant Melanoma in Sweden.
Karolin Isaksson, Dimitrios Katsarelias, Rasmus Mikiver, Ana Carneiro, Lars Ny et al.
Annals of surgical oncology, Artikel i vetenskaplig tidskrift 2019
Artikel i vetenskaplig tidskrift

Experiences of endocrine therapy after breast cancer surgery
Susanne Ahlstedt Karlsson, Roger Olofsson Bagge, Ingela Henoch, Catarina Wallengren Gustafsson
Annals of Oncology. Abstract Book of the 44th ESMO Congress (ESMO 2019) 27 September – 1 October 2019, Barcelona, Spain. Vol. 30, Suppl. 5, s. v840, Paper i proceeding 2019
Paper i proceeding

Patient experiences with isolated limb perfusion for malignant melanoma – A qualitative study
M. Ekenberg, H. Wesslau, Roger Olofsson Bagge, My Engström
European Journal of Oncology Nursing, Artikel i vetenskaplig tidskrift 2019
Artikel i vetenskaplig tidskrift

Visar 41 - 50 av 66

2016

Present and future role of surgery in metastatic gastrointestinal malignancies
Peter Naredi, Roger Olofsson Bagge
Current Opinion in Oncology, Artikel i vetenskaplig tidskrift 2016
Artikel i vetenskaplig tidskrift

Clinical Response and Regional Toxicity Following Isolated Limb Infusion Compared with Isolated Limb Perfusion for In-Transit Melanoma
L. A. Dossett, Ilan Ben-Shabat, Roger Olofsson Bagge, J. S. Zager
Annals of Surgical Oncology, Artikel i vetenskaplig tidskrift 2016
Artikel i vetenskaplig tidskrift

2015

Melphalan, Antimelanoma Immunity, and Inflammation-Letter.
Anna Martner, Junko Johansson, Ilan Ben-Shabat, Roger Olofsson Bagge
Cancer research, Artikel i vetenskaplig tidskrift 2015
Artikel i vetenskaplig tidskrift

Extraction of a foreign body in the liver using single incision laparoscopic surgery: A new application for minimally invasive surgical procedures
V. Belgrano, Roger Olofsson Bagge, C. Scordamaglia, R. Scordamaglia
Wideochirurgia I Inne Techniki Maloinwazyjne, Artikel i vetenskaplig tidskrift 2015
Artikel i vetenskaplig tidskrift

Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.
Michael Gnant, Georg Pfeiler, Peter C Dubsky, Michael Hubalek, Richard Greil et al.
Lancet (London, England), Artikel i vetenskaplig tidskrift 2015
Artikel i vetenskaplig tidskrift

Determination of 177Lu-octreotate activity concentration in vivo using intraoperative gamma probes - a comparative study
Viktor Sandblom, Ingun Ståhl, Roger Olofsson, Eva Forssell-Aronsson
Cancerfondens planeringsgrupp för onkologisk radionuklidterapis vintermöte 2015, 22-23 januari, Umeå, Sverige., Konferensbidrag (offentliggjort, men ej förlagsutgivet) 2015
Konferensbidrag (offentliggjort, men ej förlagsutgivet)

Visar 41 - 50 av 66

Sidansvarig: Susanne Lj Westergren|Sidan uppdaterades: 2013-10-10
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?

Denna text är utskriven från följande webbsida:
http://surgery.gu.se/personal/?languageId=100000&disableRedirect=true&returnUrl=http%3A%2F%2Fsurgery.gu.se%2FDepartment%2Bof%2BSurgery%2Fstaff%2F%3FpublicationPageNumber%3D5%26selectedTab%3D2%26languageId%3D100001%26userId%3Dxoloro%26userName%3DRoger%2BOlofsson%2BBagge&publicationPageNumber=5&selectedTab=2&userId=xoloro&userName=Roger+Olofsson+Bagge
Utskriftsdatum: 2020-05-28